TrialCancer research and treatment2017

Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program.

Myoung Kyun Son et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.